131 related articles for article (PubMed ID: 37499209)
21. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma?
Hu Y; Hu C; Zhang H; Ping Y; Chen LQ
Ann Surg Oncol; 2010 Mar; 17(3):784-90. PubMed ID: 19953333
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of positive lymph node regression grade to neoadjuvant chemoradiation for esophageal squamous cell carcinoma.
Yehan Z; Ying L; Peng G; Zongyao H; Chengmin Z; Hong Y; Sheng Q; Jie Z; Yi W; Xuefeng L; Wenwu H; Qifeng W; Yang L
J Surg Oncol; 2024 Mar; 129(4):708-717. PubMed ID: 38124398
[TBL] [Abstract][Full Text] [Related]
23. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma].
Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881
[TBL] [Abstract][Full Text] [Related]
24. Survival Impact of Total Resected Lymph Nodes in Esophageal Cancer Patients With and Without Neoadjuvant Chemoradiation.
Ho HJ; Chen HS; Hung WH; Hsu PK; Wu SC; Chen HC; Wang BY
Ann Surg Oncol; 2018 Dec; 25(13):3820-3832. PubMed ID: 30284131
[TBL] [Abstract][Full Text] [Related]
25. The prognostic value of residual nodal disease following neoadjuvant chemoradiation for esophageal cancer in patients with complete primary tumor response.
Blackham AU; Yue B; Almhanna K; Saeed N; Fontaine JP; Hoffe S; Shridhar R; Frakes J; Coppola D; Pimiento JM
J Surg Oncol; 2015 Nov; 112(6):597-602. PubMed ID: 26394724
[TBL] [Abstract][Full Text] [Related]
26. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
27. Thoracolaparoscopic dissection of esophageal lymph nodes without esophagectomy is feasible in human cadavers and safe in a porcine survival study.
Künzli HT; van Berge Henegouwen M; Gisbertz S; Seldenrijk C; Kuijpers K; Bergman J; Wiezer M; Weusten B
Dis Esophagus; 2016 Aug; 29(6):649-55. PubMed ID: 26228037
[TBL] [Abstract][Full Text] [Related]
28. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
29. Impact of neoadjuvant chemotherapy on nodal regression and survival in oesophageal adenocarcinoma.
Evans RP; Kamarajah SK; Kunene V; Zardo D; Elshafie M; Griffiths EA
Eur J Surg Oncol; 2022 May; 48(5):1001-1010. PubMed ID: 34974947
[TBL] [Abstract][Full Text] [Related]
30. Significance of tumour regression in lymph node metastases of gastric and gastro-oesophageal junction adenocarcinomas.
Reim D; Novotny A; Friess H; Slotta-Huspenina J; Weichert W; Ott K; Dislich B; Lorenzen S; Becker K; Langer R
J Pathol Clin Res; 2020 Oct; 6(4):263-272. PubMed ID: 32401432
[TBL] [Abstract][Full Text] [Related]
31. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
[TBL] [Abstract][Full Text] [Related]
32. Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma.
Kandilis A; Iniguez CB; Khalil H; Mazzola E; Jaklitsch MT; Swanson SJ; Bueno R; Wee JO
JTCVS Open; 2021 Mar; 5():135-147. PubMed ID: 36003158
[TBL] [Abstract][Full Text] [Related]
33. Validity of upfront surgery for patients with unsuspected lymph node metastasis in esophageal cancer: a propensity scoring matching study.
Park JK; Kim JJ; Moon SW; Cho DG
J Cardiothorac Surg; 2018 Jun; 13(1):62. PubMed ID: 29880029
[TBL] [Abstract][Full Text] [Related]
34. A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.
Langer R; Becker K; Zlobec I; Gertler R; Sisic L; Büchler M; Lordick F; Slotta-Huspenina J; Weichert W; Höfler H; Feith M; Ott K
Ann Surg Oncol; 2014 Mar; 21(3):915-21. PubMed ID: 24281419
[TBL] [Abstract][Full Text] [Related]
35. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
36. Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma.
Davies AR; Myoteri D; Zylstra J; Baker CR; Wulaningsih W; Van Hemelrijck M; Maisey N; Allum WH; Smyth E; Gossage JA; Lagergren J; Cunningham D; Green M;
Br J Surg; 2018 Nov; 105(12):1639-1649. PubMed ID: 30047556
[TBL] [Abstract][Full Text] [Related]
37. Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery.
Hagi T; Makino T; Yamasaki M; Yamashita K; Tanaka K; Saito T; Takahashi T; Kurokawa Y; Motoori M; Kimura Y; Nakajima K; Morii E; Eguchi H; Doki Y
Ann Surg; 2022 Jun; 275(6):1121-1129. PubMed ID: 32910622
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
[TBL] [Abstract][Full Text] [Related]
39. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.
Kim MP; Correa AM; Lee J; Rice DC; Roth JA; Mehran RJ; Walsh GL; Ajani JA; Maru DM; Chang JY; Marom EM; Macapinlac HA; Lee JH; Vaporciyan AA; Rice T; Swisher SG; Hofstetter WL
Ann Thorac Surg; 2010 Sep; 90(3):884-90; discussion 890-1. PubMed ID: 20732513
[TBL] [Abstract][Full Text] [Related]
40. Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
Lu RD; Wei ZD; Liu YX; Tian D; Zhang HL; Shang QX; Hu WP; Yang L; Yang YS; Chen LQ
BMC Cancer; 2024 Feb; 24(1):177. PubMed ID: 38317075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
